Cell Biochemistry and Biophysics

, Volume 68, Issue 1, pp 1–8 | Cite as

Inhibition of MLC20 Phosphorylation Downstream of Ca2+ and RhoA: A Novel Mechanism Involving Phosphorylation of Myosin Phosphatase Interacting Protein (M-RIP) by PKG and Stimulation of MLC Phosphatase Activity

  • Sunila Mahavadi
  • Ancydimpy Nalli
  • Othman Al-Shboul
  • Karnam S. MurthyEmail author
Original Paper


Previous studies have shown that cGMP-dependent protein kinase (PKG) act on several targets in the contractile pathway to reduce intracellular Ca2+ and/or augment RhoA-regulated myosin light chain phosphatase (MLCP) activity and cause muscle relaxation. Recent studies have identified a novel protein M-RIP that associates with MYPT1, the regulatory subunit of MLCP. Herein, we examine whether PKG enhance MLCP activity downstream of Ca2+ and RhoA via phosphorylation of M-RIP in gastric smooth muscle cells. Treatment of permeabilized muscle cells with 10 μM Ca2+ caused an increase in MLC20 phosphorylation and muscle contraction, but had no effect on Rho kinase activity. Activators of PKG (GSNO or cGMP) decreased MLC20 phosphorylation and contraction in response to 10 μM Ca2+, implying existence of inhibitory mechanism independent of Ca2+ and RhoA. The effect of PKG on Ca2+-induced MLC20 phosphorylation was attenuated by M-RIP siRNA. Both GSNO and 8-pCPT-cGMP induced phosphorylation of M-RIP; phosphorylation was accompanied by an increase in the association of M-RIP with MYPT1 and MLCP activity. Taken together, these results provide evidence that PKG induces phosphorylation of M-RIP and enhances its association with MYPT1 to augment MLCP activity and MLC20 dephosphorylation and inhibits muscle contraction, downstream of Ca2+- or RhoA-dependent pathways.


Smooth muscle  Relaxation  cGMP-dependent protein kinase  cGMP 



This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant to KSM (DK28300).


  1. 1.
    Murthy, K. S. (2006). Signaling for contraction and relaxation in smooth muscle of the gut. Annual Review of Physiology, 68, 345–374.PubMedCrossRefGoogle Scholar
  2. 2.
    Somlyo, A. P., & Somlyo, A. V. (2003). Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiological Reviews, 83(4), 1325–1358.PubMedGoogle Scholar
  3. 3.
    Kamm, K. E., & Stull, J. T. (2011). Signaling to myosin regulatory light chain in sarcomeres. Journal of Biological Chemistry, 286(12), 9941–9947.PubMedCrossRefGoogle Scholar
  4. 4.
    de Godoy, M. A., & Rattan, S. (2011). Role of Rho kinase in the functional and dysfunctional tonic smooth muscles. Trends in Pharmacological Sciences, 32, 384–393.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Ito, M., Nakano, T., Erdodi, F., & Hartshorne, D. J. (2004). Myosin phosphatase: Structure, regulation and function. Molecular and Cellular Biochemistry, 259, 197–209.PubMedCrossRefGoogle Scholar
  6. 6.
    Riddick, N., Ohtani, K., & Surks, H. K. (2008). Targeting by myosin phosphatase-RhoA interacting protein mediates RhoA/ROCK regulation of myosin phosphatase. Journal of Cellular Biochemistry, 103, 1158–1170.PubMedCrossRefGoogle Scholar
  7. 7.
    Grassie, M. E., Moffat, L. D., Walsh, M. P., & MacDonald, J. A. (2011). The myosin phosphatase targeting protein (MYPT) family: A regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1delta. Archives of Biochemistry and Biophysics, 510, 147–159.PubMedCrossRefGoogle Scholar
  8. 8.
    Matsumura, F., & Hartshorne, D. J. (2008). Myosin phosphatase target subunit: Many roles in cell function. Biochemical and Biophysical Research Communications, 369, 149–156.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Gebbink, M. F., Kranenburg, O., Poland, M., van Horck, F. P., Houssa, B., & Moolenaar, W. H. (1997). Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: Control of neuronal morphology. Journal of Cell Biology, 137, 1603–1613.PubMedCrossRefGoogle Scholar
  10. 10.
    Mulder, J., Poland, M., Gebbink, M. F., Calafat, J., Moolenaar, W. H., & Kranenburg, O. (2003). p116Rip is a novel filamentous actin-binding protein. Journal of Biological Chemistry, 278, 27216–27223.PubMedCrossRefGoogle Scholar
  11. 11.
    Mulder, J., Ariaens, A., van den Boomen, D., & Moolenaar, W. H. (2004). p116Rip targets myosin phosphatase to the actin cytoskeleton and is essential for RhoA/ROCK-regulated neuritogenesis. Molecular Biology of the Cell, 15, 5516–5527.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Mulder, J., Ariaens, A., van Horck, F. P., & Moolenaar, W. H. (2005). Inhibition of RhoA-mediated SRF activation by p116Rip. FEBS Letters, 579, 6121–6127.PubMedCrossRefGoogle Scholar
  13. 13.
    Surks, H. K., Richards, C. T., & Mendelsohn, M. E. (2003). Myosin phosphatase-Rho interacting protein. A new member of the myosin phosphatase complex that directly binds RhoA. Journal of Biological Chemistry, 278, 51484–51493.PubMedCrossRefGoogle Scholar
  14. 14.
    Surks, H. K., Riddick, N., & Ohtani, K. (2005). M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells. Journal of Biological Chemistry, 280, 42543–42551.PubMedCrossRefGoogle Scholar
  15. 15.
    Surks, H. K., & Mendelsohn, M. E. (2003). Dimerization of cGMP-dependent protein kinase 1alpha and the myosin-binding subunit of myosin phosphatase: Role of leucine zipper domains. Cellular Signalling, 15, 937–944.PubMedCrossRefGoogle Scholar
  16. 16.
    Koga, Y., & Ikebe, M. (2005). p116Rip decreases myosin II phosphorylation by activating myosin light chain phosphatase and by inactivating RhoA. Journal of Biological Chemistry, 280, 4983–4991.PubMedCrossRefGoogle Scholar
  17. 17.
    Sharma, A. K., Zhou, G. P., Kupferman, J., Surks, H. K., Christensen, E. N., Chou, J. J., et al. (2008). Probing the interaction between the coiled coil leucine zipper of cGMP-dependent protein kinase Iα and the C terminus of the myosin binding subunit of the myosin light chain phosphatase. Journal of Biological Chemistry, 283, 32860–32869.PubMedCrossRefGoogle Scholar
  18. 18.
    Zhou, G. P. (2011). The structural determinations of the leucine zipper coiled-coil domains of the cGMP-dependent protein kinase Ialpha and its interaction with the myosin binding subunit of the myosin light chains phosphatase. Protein and Peptide Letters, 18, 966–978.PubMedCrossRefGoogle Scholar
  19. 19.
    Huang, Q. Q., Fisher, S. A., & Brozovich, F. V. (2004). Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation. Journal of Biological Chemistry, 279, 597–603.PubMedCrossRefGoogle Scholar
  20. 20.
    Yuen, S., Ogut, O., & Brozovich, F. V. (2011). MYPT1 protein isoforms are differentially phosphorylated by protein kinase G. Journal of Biological Chemistry, 286, 37274–37279.PubMedCrossRefGoogle Scholar
  21. 21.
    Nakamura, M., Ichikawa, K., Ito, M., Yamamori, B., Okinaka, T., Isaka, N., et al. (1999). Effects of the phosphorylation of myosin phosphatase by cyclic GMP-dependent protein kinase. Cellular Signalling, 11, 671–676.PubMedCrossRefGoogle Scholar
  22. 22.
    Surks, H. K., Mochizuki, N., Kasai, Y., Georgescu, S. P., Tang, K. M., Ito, M., et al. (1999). Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science, 286, 1583–1587.PubMedCrossRefGoogle Scholar
  23. 23.
    Given, A. M., Ogut, O., & Brozovich, F. V. (2007). MYPT1 mutants demonstrate the importance of aa 888–928 for the interaction with PKGIalpha. American Journal of Physiology Cell Physiology, 292, C432–C439.PubMedCrossRefGoogle Scholar
  24. 24.
    Lee, J. H., Palaia, T., & Ragolia, L. (2012). Impaired insulin-stimulated myosin phosphatase Rho-interacting protein signaling in diabetic Goto-Kakizaki vascular smooth muscle cells. American Journal of Physiology Cell Physiology, 302, C1371–C1381.PubMedCrossRefGoogle Scholar
  25. 25.
    Murthy, K. S., Zhou, H., Grider, J. R., & Makhlouf, G. M. (2003). Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA. American Journal of Physiology Gastrointestinal and Liver Physiology, 284, G1006–G1016.PubMedGoogle Scholar
  26. 26.
    Murthy, K. S., & Makhlouf, G. M. (1996). Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. Molecular Pharmacology, 50, 870–877.PubMedGoogle Scholar
  27. 27.
    Murthy, K. S. (2008). Contractile agonists attenuate cGMP levels by stimulating phosphorylation of cGMP-specific PDE5; an effect mediated by RhoA/PKC-dependent inhibition of protein phosphatase 1. British Journal of Pharmacology, 153, 1214–1224.PubMedCrossRefGoogle Scholar
  28. 28.
    Begum, N., Duddy, N., Sandu, O., Reinzie, J., & Ragolia, L. (2000). Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: Evaluation of the role of Rho kinase and phosphatidylinositol-3-kinase-dependent signaling pathways. Molecular Endocrinology, 14, 1365–1376.PubMedCrossRefGoogle Scholar
  29. 29.
    Shimizu, H., Ito, M., Miyahara, M., Ichikawa, K., Okubo, S., Konishi, T., et al. (1994). Characterization of the myosin-binding subunit of smooth muscle myosin phosphatise. Journal of Biological Chemistry, 269, 30407–30411.PubMedGoogle Scholar
  30. 30.
    Wu, Y., Muranyi, A., Erdodi, F., & Hartshorne, D. J. (2005). Localization of myosin phosphatase target subunit and its mutants. Journal of Muscle Research and Cell Motility, 26, 123–134.PubMedCrossRefGoogle Scholar
  31. 31.
    Khatri, J. J., Joyce, K. M., Brozovich, F. V., & Fisher, S. A. (2001). Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. Journal of Biological Chemistry, 276, 37250–37257.PubMedCrossRefGoogle Scholar
  32. 32.
    Sauzeau, V., Le Jeune, H., Cario-Toumaniantz, C., Smolenski, A., Lohmann, S. M., Bertoglio, J., et al. (2000). Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2 + sensitization of contraction in vascular smooth muscle. Journal of Biological Chemistry, 275, 21722–21729.PubMedCrossRefGoogle Scholar
  33. 33.
    Wu, X., Haystead, T. A., Nakamoto, R. K., Somlyo, A. V., & Somlyo, A. P. (1998). Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin, Synergism with cyclic nucleotide-activated kinase. Journal of Biological Chemistry, 273, 11362–11369.PubMedCrossRefGoogle Scholar
  34. 34.
    Wooldridge, A. A., MacDonald, J. A., Erdodi, F., Ma, C., Borman, M. A., Hartshorne, D. J., et al. (2004). Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides. Journal of Biological Chemistry, 279, 34496–34504.PubMedCrossRefGoogle Scholar
  35. 35.
    Kato, M., Blanton, R., Wang, G. R., Judson, T. J., Abe, Y., Myoishi, M., et al. (2012). Direct binding and regulation of RhoA by Cyclic GMP-dependent protein kinase Ialpha. Journal of Biological Chemistry, 287(49), 41342–41351.PubMedCrossRefGoogle Scholar
  36. 36.
    Khromov, A. S., Wang, H., Choudhury, N., McDuffie, M., Herring, B. P., Nakamoto, R., et al. (2006). Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation. Proceedings of the National Academy of Sciences of the United States of America, 103(7), 2440–2445.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Yong, J., Tan, I., Lim, L., & Leung, T. (2006). Phosphorylation of myosin phosphatase targeting subunit 3 (MYPT3) and regulation of protein phosphatase 1 by protein kinase A. Journal of Biological Chemistry, 281, 31202–31211.PubMedCrossRefGoogle Scholar
  38. 38.
    Lee, E., Hayes, D. B., Langsetmo, K., Sundberg, E. J., & Tao, T. C. (2007). Interactions between the leucine-zipper motif of cGMP-dependent protein kinase and the C-terminal region of the targeting subunit of myosin light chain phosphatase. Journal of Molecular Biology, 373, 1198–1212.PubMedCrossRefGoogle Scholar
  39. 39.
    Bhetwal, B. P., An, C. L., Fisher, S. A., & Perrino, B. A. (2011). Regulation of basal LC20 phosphorylation by MYPT1 and CPI-17 in murine gastric antrum, gastric fundus, and proximal colon smooth muscles. Neurogastroenterology and Motility, 23, e425–e436.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Sunila Mahavadi
    • 1
  • Ancydimpy Nalli
    • 1
  • Othman Al-Shboul
    • 1
  • Karnam S. Murthy
    • 1
    Email author
  1. 1.Department of Physiology and BiophysicsVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations